SCHEMBL3395798

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL3395802	1.00	MC4R (0.54)	MC4RSIGMAR1ACHEADRA2ALMNA
	SCHEMBL3393342	0.95	MC4R (0.56)	MC4RSIGMAR1ACHELMNAPOLB
	SCHEMBL3393340	0.95	MC4R (0.56)	MC4RSIGMAR1ACHELMNAPOLB
	SCHEMBL8176219	0.95	MC4R (0.56)	MC4RSIGMAR1ACHELMNAPOLB
	SCHEMBL13700887	0.78	CCR3 (0.57)	SIGMAR1HTR1ACCR3
	SCHEMBL2606119	0.78	ADRA2A (0.53)	ADRA2A
	SCHEMBL12568590	0.77	CYP1A2 (0.64)	ADRA2A
	SCHEMBL9733679	0.77	CYP1A2 (0.64)	ADRA2A
	SCHEMBL11470450	0.76	ADRA2A (0.51)	ADRA2A
	SCHEMBL25645586	0.76	ADRA2A (0.51)	ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.